Ian Maidment is a Professor in Clinical Pharmacy at Aston University. Prior to moving to academia in 2012, he spent 20+ years in practice including community pharmacy and acute pharmacy. The majority of his career was as a specialist clinical pharmacist in dementia care/mental health; he was also chief pharmacist in two NHS Trusts.
He has strong links with the local NHS and the NIHR. Currently, he is joint West Midlands NIHR Community Trust Specialty Lead, member of the NIHR Dementia Portfolio Development Group and joint chair of the Society of Academic Primary Care Medication Optimisation Group.
Since 2014 he has obtained £1,111K in grant income (as chief investigator) including four NIHR grants (MEDREV, MEMORABLE, RESOLVE, MEDIATE); he has also been a co-investigator on a further £3,963K of grants and a NIHR fellowship for which he is the main supervisor [£71K].
His research is focused on medication management in vulnerable populations including mental health and dementia. He has published over 110 papers in peer-reviewed journals including BMJ and the British Journal of Psychiatry and presented at 50+ international conferences/workshops in USA, Australia and most countries in Europe.
Areas of Expertise (5)
Medication Management for Older People
Aston University: PhD, Pharmacy 2013
Medication-related adverse events in older people with dementia; causes and possible solutions
University of Kent: MA, Health Service Research 2010
De Montfort University: Diploma, Psychiatric Pharmacy, 1996
University of Bath: BPharm, Pharmacy 1986
- General Pharmaceutical Council : Member
- Royal Pharmaceutical Society : Founding Member
- College of Mental Health Pharmacy : Member
Media Appearances (7)
Essential Pharma drops plans to withdraw bipolar drug amid competition investigation
The Times online
A drug company accused of trying to rip off taxpayers has halted plans to withdraw a bipolar drug after the competition watchdog opened an investigation into whether it had broken the law.
Aston Univeristy to research role of community pharmacy during pandemics
Pharmacy Business online
“With over 11,700 high street locations, community pharmacies can ensure people from different socio-economic groups and black, Asian and minority ethnic (BAME) groups have equal access to vaccination and advice,” academic pharmacist at Aston University Dr Ian Maidment said, adding: “This project will enable us to understand how, why, for whom and when community pharmacy can effectively support the public health response to pandemics such as Covid-19 and other future health emergencies.”
Research tackles hidden 'tablet overload' as COVID isolation fears grow
Medical Xpress online
The team behind the MEMORABLE (MEdication Management in Older people: Realist Approaches Based on Literature and Evaluation) study, funded by the National Institute for Health Research (NIHR) and led by Dr. Ian Maidment, say a new approach rooted in real-world experience is needed to tackle the "unrivalled complexity" many older people and family carers face.
Patients told not to stop anticholinergic drugs after study links them to dementia
The Pharmaceutical Journal online
However, Ian Maidment, senior lecturer in clinical pharmacy at Aston University and lead pharmacist on the study, has advised that patients should not panic or stop taking their medication.
'Don't panic' over medicines' link to dementia, says expert
However, Dr Ian Maidment of Aston University, who is one of the investigators, has told people "not to panic" and to consult their doctors as the risks of not taking certain drugs can be outweighed by the benefits of staying on them.
Dementia risk linked to some medicines
The most important thing is "not to panic", according to Dr Ian Maidment, from Aston University.
People with dementia need more support managing their medication
Medical Xpress online
Lead researcher Dr Ian Maidment, Senior Lecturer in Clinical Pharmacy at Aston said: "Our study found incorrect dosing, forgetting to give the medication and taking medicines which should have been stopped."
Research Grants (4)
PERISCOPE: A rapid realist review of community pharmacy support for the public health agenda during the COVID-19 pandemic and future health emergencies
UKRI (Medical Research Council) £85,442
Research for Patient Benefit
2014 Improving the Management of Behaviour that Challenges associated with dementia in Care Homes: protocol for pharmacy-health psychology intervention feasibility study (MEDREV)
Pharmacy Research UK
Pharmacy Research UK $54,000
2014 A qualitative scoping study exploring the role of the community pharmacist in medication management in people with dementia dwelling in the community.
Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysisAge and Ageing
2020 Dementia affects more than 40 million people with direct healthcare costs of $818 billion in 2015 . Dementia is characterised by irreversible and progressive cognitive impairment, with consequent disability and dependence. ‘Cognitive impairment’ itself refers to problems with cognitive abilities such as memory, problem solving, learning, perception and language.
Does the Formulation of Oral Solid Dosage Forms Affect Acceptance and Adherence in Older Patients? A Mixed Methods Systematic ReviewJournal of the American Medical Directors Association
2020 Age-related changes mean that the older population can encounter barriers toward taking medication orally. Further work is needed to identify the characteristics of oral solid dosage forms that will improve patient acceptance and adherence. The aim of this systematic review was to identify if and how formulation aspects of oral solid dosage forms affect acceptance and adherence in older people.
How, why, for whom and in what context, do sexual health clinics provide an environment for safe and supported disclosure of sexual violence: protocol for a realist reviewBMJ Open
2020 Supporting people subjected to sexual violence includes provision of sexual and reproductive healthcare. There is a need to ensure an environment for safe and supported disclosure of sexual violence in these clinical settings. The purpose of this research is to gain a deeper understanding of how, why, for whom and in what circumstances safe and supported disclosure occurs in sexual health services.
MEDREV (pharmacy-health psychology intervention in people living with dementia with behaviour that challenges): the feasibility of measuring clinical outcomes and costs of the interventionBMC Health Services Research
2020 People living with dementia in care homes frequently exhibit “behaviour that challenges”. Anti-psychotics are used to treat such behaviour, but are associated with significant morbidity. This study researched the feasibility of conducting a trial of a full clinical medication review for care home residents with behaviour that challenges, combined with staff training. This paper focusses on the feasibility of measuring clinical outcomes and intervention costs.
Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug UseJournal of Alzheimer's Disease
2020 Benzodiazepines and anticholinergic drugs have been implicated in causing cognitive decline and potentially increasing dementia risk. However, evidence for an association with neuropathology is limited.